InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by Brainard Diana, Chairman & CEO. Officer active across 2 companies, notably Allovir, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €121k. The latest transaction was filed on 18 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€120,55729,135 shares@ €4.1379100.0% of flow
Common Stock
SEC:0000899243-22-019216:0·
0315,000 shares0
Common Stock
SEC:0000899243-22-013332:0·
018,360 shares0
Common Stock
SEC:0001209191-21-064508·
018,360 shares0
Common Stock
SEC:0001209191-21-064508:0·
030,000 shares0
Common Stock
SEC:0000899243-21-019779·
030,000 shares0
Common Stock
SEC:0000899243-21-019779:0·
6 of 6 declarations
About Brainard Diana
Diana Brainard is the Chief Executive Officer and Director of Allovir, Inc. and Nektar Therapeutics. She oversees the operations and strategy of these biopharmaceutical companies, contributing to innovation and the development of new treatments.
